Fasken Martineau DuMoulin LLP advised Research Capital Corporation on the matter. GeneTether Therapeutics Inc. (CSE: GTTX), an innovative genetic medicines company, completed an initial public offering of...
GeneTether Therapeutics Inc.’s C$4.5 Million Initial Public Offering
Nevada Lithium Resources Inc.’s $5.51 Million Brokered Private Placement
Cassels acted for agents. Nevada Lithium Resources Inc. closed a brokered private placement of 12,257,890 special warrants at a price of $0.45 per special warrant for...
Eat Well’s $4.83 Million Brokered Private Placement
Cassels acted for agents. On December 23, 2021, Eat Well Investment Group Inc. closed a brokered private placement of 8,799,637 special warrants at a price of...
Appili Therapeutics’ C$7 Million Rights Offering
McCarthy Tétrault advised the syndicate of agents in connection with Appili Therapeutics’ offering. Appili Therapeutics Inc. closed its previously announced public offering of units. Pursuant to the Offering,...
Kiaro Holdings Corp.’s $3.75 Million Private Placement
Wildeboer Dellelce LLP acted for the agents. Kiaro Holdings Corp. (TSXV: KO), an independent, omni-channel cannabis retailer and distributor with storefronts across British Columbia, Saskatchewan and...
Kovo Healthtech’s $1.2 Million Private Placement
Wildeboer Dellelce LLP acted for Research Capital in connection with the offering. Kovo Healthtech Corporation, a leader in healthcare Billing-as-a-Service, completed a brokered private placement of...
Valeo Pharma Inc.’s C$11.5 Million Bought Deal
Fasken advised the sole bookrunner. On June 29, 2021, Valeo Pharma Inc., a Canadian pharmaceutical company, announced the closing of its “bought deal” short form prospectus...
Group Ten Metals’ $6 Million Private Placement
Cassels acted for the agents. On June 16, 2021, Group Ten Metals Inc. completed a brokered private placement financing of 15,000,000 units at a price of...